Orchestra BioMed Holdings, Inc.'s revenue has grown 95% a year over three years. Revenue growth, 3-year annual rate: +95% (Biotechnology median +21%). Years of annual history on file: 5, FY2021 to FY2025, as filed.

OBIOOrchestra BioMed Holdings, Inc.

Healthcare

$5.59+57% 1Y

$5.59

$3.4952 weeks$6.36

Is it growing?

Mixed

Neither accelerating nor breaking down: revenue growing +986% year on year, but operating margin narrowing (−8768.0 points).

1 good, 1 to watch, 1 without data

Revenue trend+986% in a year

Trailing-twelve-month revenue vs a year earlier, from the company's own filings.

Margin direction−8768.0 points operating

Trailing-twelve-month operating margin, -11952.8% now against -3184.8% a year earlier.

All from SEC EDGAR, as of Jun 30, 2026.

Where this answer is blind. These are trailing numbers from the filings, not forecasts: an acquisition or a one-off year can flatter them, so check the quarters.